H&R AG / Key word(s): Quarter Results/9-month figures 03.11.2014 17:22 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc notification conforming to article 15 of the German law governing the trading of securities (WpHG) H&R AG: Preliminary figures for third quarter of 2014 Salzbergen (Germany), November 3, 2014. The company H&R Aktiengesellschaft (ISIN DE0007757007) has increased - according to preliminary calculations - its Group operating profit (EBITDA) in the third quarter of fiscal year 2014 by more than 9% to EUR10.6 million (Q3-2013: EUR9.7 million). EBIT improved from EUR -8.6 million in the third quarter 2013 to EUR4,8 million in this year's third quarter. Revenues for the third quarter 2014 of EUR 265.6 million were around 25% lower (Q3-2013: EUR353.6 million) than previous years figure. Profitability increased significantly in the course of the year, and compared to the previous quarters. This is reflected as well in earnings before tax (EBT), as well as in the Group's net earnings, which have increased from EUR-11.7 million and EUR-8.4 million in the third quarter of 2013 to EUR1.2 million and EUR0.8 million in the third quarter of fiscal year 2014. The company achieved, over the entire nine-month period, provisionally and with 14.3% lower sales of EUR806.3 million (9 months of 2013: EUR941.1 million), an increase of 8.2% in EBITDA, totalling EUR25.2 million (equivalent period of the previous year: EUR23.3 million). EBIT sums up to EUR8.1 million (previous year's period: EUR-7.4 million). Earnings before tax (EBT) for the period increased to EUR-2,4 million (Nine months 2013: EUR-16,0 million). Net earnings went up to EUR-1.9 million (Nine months 2013: EUR-11.7 million). The reasons for the described decline in sales are significantly reduced raw material costs, which highly affected our revenue levels. Demand and sold quantities on the other hand ran stable. Reasons for the improved earnings included market-related developments such as the rise, since the summer, of base oil prices. At the same time, in-house measures have likewise had a positive impact. These include raw-materials management and the use of higher-quality feedstock, which has made a sustainable contribution to the reduced presence of by-products with lower margins. This year's results are, unlike those of the previous years' period, unaffected by extraordinary special factors. In the past quarter, H&R AG generated a positive operating cash flow of EUR14.0 million (Q3-2013: EUR50.6 million.), the free cash flow was EUR9.5 million (Q3-2013: EUR46.8 million). In comparison of the nine month periods, the operating cash flow decreased from EUR83.2 million to EUR-18.3 million; Free cash flow lowered from EUR70.5 million to EUR-30.5 million. This development was based on positive special effects in fiscal year 2013, when cash flows benefitted from the reduction of inventories as a result of the manufacturing production in the Salzbergen refinery. The balance sheet total increased in the nine months period from EUR594.7 million to EUR707.6 million. The company's equity rose from EUR189.2 million to EUR262.4 million. The noticeable changes should be seen in the context of the increase in capital carried out in September 2014 and, as part of the same operation, the successful incorporation of the majority (51% of voting rights) of the Chinese business activities of the Hansen & Rosenthal Group into H&R AG. When it comes to the final quarter of 2014, H&R Aktiengesellschaft is expecting - on the basis of currently available knowledge - comparable developments in terms of the business in particular and the market in general. These will include sales of around EUR1.1 billion, and therefore below those of previous years. The Board's expectations regarding EBITDA are reaffirmed in the terms expressed in the most recent report; that of the first half year of 2014. The final financial figures, along with further information on business developments to date, will be published on 14th November 2014, as planned, in the report on the first three quarters. Contact: H&R AG, Investor Relations / Kommunikation, Ties Kaiser Neuenkirchener StraÃe 8, 48499 Salzbergen Phone.: +49 40 43218-321, Fax: +49 40 43218-390 Mail: Ties.Kaiser@hur.com www.hur.com H&R AG is a Prime Standard listed specialist chemicals company. It develops and manufactures crude oil-based chemical and pharmaceutical products and high-precision plastic parts. Forward-looking statements and forecasts: This ad hoc notification contains forward-looking statements. These statements are based on current estimates and forecasts made by the Executive Board and the information available to the Board at this time. Forward-looking statements should not be interpreted as guarantees that the projected future developments and results will materialise. Future developments and results are dependent on a range of factors. They comprise various risks and imponderables and rest on assumptions which may prove incorrect. We do not accept any obligation to update the forward-looking statements made in this ad-hoc communication. 03.11.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: H&R AG Neuenkirchener Str. 8 48499 Salzbergen Germany Phone: +49 (0)40 43 218 321 Fax: +49 (0)40 43 218 390 E-mail: investor.relations@hur.com Internet: www.hur.com ISIN: DE0007757007 WKN: 775700 Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard), Hamburg; Freiverkehr in Berlin, Hannover, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: H&R AG: Preliminary figures for third quarter
Top 10 Most Recent News Articles
Berlin Heals Puts Microcurrent Therapy to a Real Test
A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....
Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats
A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...
Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin
Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...
Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools
Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...
Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents
Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...
Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care
A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...
Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge
Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...
Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today
Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...
Continue Reading
Texas Restaurants Get a New Read on Customer Demand
Texas restaurant owners are being handed a sharper flashlight, and frankly it is overdue. HundredX and the Texas Restaurant Association have launched a pilot that gives TRA members access to the HundredX Restaurant Insights Platform, aiming to bring customer and market intelligence to the independent operators and regional chains that usually cannot pay big-company prices...
Continue Reading
Knowles Expands Its Teacher Pipeline With 39 Fellows
Thirty-Nine Teachers Is Not a Trivial Signal Thirty-nine new math and science teachers may not rattle public markets, but it says plenty about where the real strain sits in American education. The Knowles Teacher Initiative has named its 2026 Teaching Fellowship class, its largest ever, and the timing is dead serious: schools are still wrestling with recruiting and...
Continue ReadingTop 5 Most Recently Viewed Articles
Investigation into GoHealth, Inc. Sparks Investor Concerns
GoHealth, Inc. Under Investigation for Alleged Securities Fraud Pomerantz LLP has initiated an investigation regarding potential claims involving investors of GoHealth, Inc. (NASDAQ: GOCO). This probe aims to determine whether the company and some of its executives have participated in misleading practices concerning their financial statements. The firm is reaching out to...
Continue Reading
Exploring the Features of the 2026 Toyota GR Corolla
Unleashing the Adventure with the 2026 Toyota GR Corolla Get ready for an adventurous experience with the all-new 2026 Toyota GR Corolla. Engineered to perfection, this vehicle is equipped with the innovative GR-FOUR All-Wheel Drive System, making it a formidable companion whether you're racing on the track or maneuvering through rugged terrains. The GR Corolla is...
Continue Reading
Tandem Diabetes Care Boosts Sales Guidance After Q3 Success
Tandem Diabetes Care Reports Impressive Q3 Financial Results Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading name in insulin delivery and diabetes management technology, has reported its financial accomplishments for the third quarter of 2024. Following an exceptional performance, the company has also increased its sales guidance for the upcoming fiscal year. Key...
Continue Reading
Green IT Services Growth: A Comprehensive Market Overview
Green IT Services Market: A Dynamic Overview The evolution of technology is more than just a trend; it represents a paradigm shift towards sustainability. As organizations embrace digital transformation, the focus on Green IT services has rapidly gained importance. The latest analyses indicate that the Green IT Services market, valued at USD 18.8 billion in recent years,...
Continue Reading
Duke Energy's Response to Hurricane Helene's Aftermath
Hurricane Helene Aftermath and Power Restoration Efforts Following the severe impact of Hurricane Helene, Duke Energy (NYSE: DUK) has made remarkable progress in restoring electrical services to over 2.16 million customers. Despite these extensive restoration efforts, around 334,000 customers are still without power, largely in Upstate South Carolina and the mountainous...
Continue Reading